-
-
-
-
-
-
-
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
-
-
-
-
-
-
-
Benchmark Reiterates Speculative Buy Rating on Harvard Bioscience Inc. (HBIO)
-
-
-
-
-
-
-
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET
-
-
-
-
-
-
-
Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024
-
-
-
-
-
-
-
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
-
-
-
-
-
-
-
Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023
-
-
-
-
-
-
-
Harvard Bioscience (HBIO) to Join Russell 2000 and 3000 Indexes
-
1,198,700 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

